mitozolomide has been researched along with Benign Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clear, M; Dady, P; MacDonald, A; McKeage, M | 1 |
| Dubbelman, R; McVie, JG; Schornagel, JH; Simonetti, G; ten Bokkel Huinink, WW | 1 |
| Barnes, D; Erickson, LC; Gibson, NW; Hartley, JA | 1 |
| Bischoff, AK; Brunner, KW; Goldhirsch, A; Joss, RA; Ryssel, HJ | 1 |
1 trial(s) available for mitozolomide and Benign Neoplasms
| Article | Year |
|---|---|
Abbreviated phase I clinical trial of i.v. mitozolomide.
Topics: Adult; Aged; Antineoplastic Agents; Clinical Trials as Topic; Drug Evaluation; Female; Hematologic Diseases; Humans; Male; Middle Aged; Nausea; Neoplasms; Nitrogen Mustard Compounds | 1986 |
3 other study(ies) available for mitozolomide and Benign Neoplasms
| Article | Year |
|---|---|
A clinical and pharmacological study of high-dose mitozolomide given in conjunction with autologous bone marrow rescue.
Topics: Adult; Aged; Bone Marrow Transplantation; Combined Modality Therapy; Female; Half-Life; Humans; Leukocyte Count; Metabolic Clearance Rate; Middle Aged; Neoplasms; Nitrogen Mustard Compounds; Platelet Count | 1992 |
Phase I study of mitozolomide on a once daily for 5 days schedule.
Topics: Adult; Aged; Antineoplastic Agents; Blood Cells; Bone Marrow; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasms; Nitrogen Mustard Compounds; Time Factors | 1990 |
Combined effects of streptozotocin and mitozolomide against four human cell lines of the Mer+ phenotype.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line; DNA Repair; Humans; Methyltransferases; Neoplasms; Nitrogen Mustard Compounds; O(6)-Methylguanine-DNA Methyltransferase; Phenotype; Streptozocin; Tumor Stem Cell Assay | 1986 |